Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAFs shape myeloid‐derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5‐lipoxygenase
Yuli Lin, Qian Cai, Yu Chen, et al.
Hepatology (2021) Vol. 75, Iss. 1, pp. 28-42
Closed Access | Times Cited: 119

Showing 1-25 of 119 citing articles:

CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor
Guiqi Zhu, Zheng Tang, Run Huang, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 149
Stromal cells in the tumor microenvironment: accomplices of tumor progression?
Yan Zhao, Meili Shen, Liangqiang Wu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 9
Open Access | Times Cited: 136
Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis
Palanisamy Nallasamy, Rama Krishna Nimmakayala, Seema Parte, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 116
Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers
Liping Pei, Yang Liu, Lin Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 108
Myeloid-derived suppressor cells in cancer and cancer therapy
Samantha Lasser, Feyza Gül Özbay Kurt, Ihor Arkhypov, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 2, pp. 147-164
Closed Access | Times Cited: 106
Metabolic reprogramming in cholangiocarcinoma
Chiara Raggi, Maria Letizia Taddei, Colin Rae, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 3, pp. 849-864
Open Access | Times Cited: 97
Immunology and immunotherapy of cholangiocarcinoma
Tim F. Greten, Robert F. Schwabe, Nabeel Bardeesy, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 6, pp. 349-365
Closed Access | Times Cited: 85
Cancer stem cells: advances in knowledge and implications for cancer therapy
Xianjing Chu, Wentao Tian, Jiaoyang Ning, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 66
CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy?
Chunxue Zhang, Yuxiang Fei, Hui Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 52
Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma
Ying Fan, Mandy Sze Man Chan, Terence K. Lee
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 4, pp. 985-999
Open Access | Times Cited: 48
Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer
Moumita Kundu, Ramesh Butti, Venketesh K. Panda, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 37
Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion
Junli Lu, Yiming Luo, Dean Rao, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 35
Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy
Tianchen Guo, Junfen Xu
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 3, pp. 1095-1116
Open Access | Times Cited: 26
Myeloid cell-derived apCAFs promote HNSCC progression by regulating proportion of CD4+ and CD8+ T cells
Feilong Ren, Lin Meng, Shize Zheng, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 2
Advances of cancer-associated fibroblasts in liver cancer
Hao Peng, Erwei Zhu, Yewei Zhang
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 40
Immunobiology of cholangiocarcinoma
Jennifer L. Tomlinson, Juan W. Valle, Sumera I. Ilyas
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 867-875
Open Access | Times Cited: 30
Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer
Yiwen Zheng, Shujin Li, Hongchao Tang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Intimate communications within the tumor microenvironment: stromal factors function as an orchestra
Bing Cheng, Qiang Yu, Wenyu Wang
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 23
Immune Cell Migration to Cancer
Allison Ryan, Minsoo Kim, Kihong Lim
Cells (2024) Vol. 13, Iss. 10, pp. 844-844
Open Access | Times Cited: 11
Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution
Fusheng Zhang, Yongsu Ma, Dongqi Li, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 11
Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment
Fusheng Zhang, Junchen Guo, Shengmiao Yu, et al.
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 929-966
Open Access | Times Cited: 10
Macrophages and tumor-associated macrophages in the senescent microenvironment: From immunosuppressive TME to targeted tumor therapy
Ming Du, Lu Sun, J.J. Guo, et al.
Pharmacological Research (2024) Vol. 204, pp. 107198-107198
Open Access | Times Cited: 9
FAP upregulates PD-L1 expression in cancer-associated fibroblasts to exacerbate T cells dysfunction and suppress anti-tumor immunity
Rongyuan Wei, Junquan Song, Chenchen Liu, et al.
Cancer Letters (2025), pp. 217475-217475
Closed Access | Times Cited: 1
Rational development of combination therapies for biliary tract cancers
James J. Harding, Danny N. Khalil, Luca Fabris, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 1, pp. 217-228
Closed Access | Times Cited: 36
Mechanism of cancer stemness maintenance in human liver cancer
Ning Liang, Tao Yang, Qian Huang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top